TriVascular Raises $60 Million
TriVascular, a Santa Rosa, Calif.-based developer of endovascular repair devices for treating abdominal aortic aneurysms, has raised $60 million in Series C funding. Pinnacle Ventures led the round, and was joined by return backers New Enterprise Associates, Delphi Ventures, MPM Capital and Kearny Venture Partners. The company previously raised $95 million, part of which was used to purchase TriVascular from Boston Scientific (which itself had purchased the company from VCs Delphi and Kearny).
13 July 2010•3 mins read
